MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Biomarkers for Parkinson´s Disease with Reflex Tears Correlate with Disease Duration

    M. Lew, S. Janga, D. Feigenbaum, D. Freire, M. Edman, W. Mack, C. Okamoto, S. Hamm-Alvarez (Los Angeles, CA, USA)

    Objective: To determine if the protein composition of reflex tears differs in Parkinson’s disease (PD) patients stratified by disease duration compared to Healthy Controls (HC).…
  • MDS Virtual Congress 2020

    Non-mercaptalbumin as a potential biomarker of oxidative stress in Parkinson’s and PARK2 disease

    S. Ueno, T. Hatano, A. Okuzumi, S. Saiki, Y. Oji, A. Mori, T. Koinuma, M. Fujimaki, H. Takeshige-Amano, A. Kondo, N. Yoshikawa, T. Nojiri, M. Kurano, K. Yasukawa, Y. Yatomi, H. Ikeda, N. Hattori (Tokyo, Japan)

    Objective: To elucidate the oxidized albumin ratio, which is the redox ratio of human non-mercaptalbumin (HNA) to serum albumin (%HNA), as a biomarker in parkinsonism.…
  • MDS Virtual Congress 2020

    Maladaptive use of LD/CD tablets as painkillers causing Dopamine Dysregulation Syndrome in 4 patients of Advanced Parkinson’s Disease

    M. Gautam, K. Shukla, N. Sawal (Chandigarh, India)

    Objective: To study four cases of maladaptive use of levodopa/carbidopa (LD/CD) as painkillers causing Dopamine dysregulation syndrome (DDS) in Parkinson’s disease (PD) patient in a…
  • MDS Virtual Congress 2020

    Frequency of Impulse Control Disorders and Other Related Behaviors in People with Parkinson’s Disease

    G. Xavier-Souza, A. Mendoza, I. Alves, L. Almeida, G. Valença (Salvador, Brazil)

    Objective: To identify the frequency of impulse control disorders (ICDs) and other related behaviors (i.e. punding, hobbyism, walkabout and dopamine dysregulation syndrome) in people with…
  • MDS Virtual Congress 2020

    Three-year safety and clinical outcomes from the PD-1101 trial of AADC gene therapy for advanced Parkinson’s disease

    C. Christine, R. Richardson, A. Van Laar, M. Thompson, K. Herbert, C. Li, G. Liang, E. Fine, P. Larson (San Francisco, CA, USA)

    Objective: To present preliminary 3-year data from the PD-1101 trial of VY-AADC01 for advanced Parkinson’s disease (PD) with motor fluctuations. Background: This 3-year phase 1b…
  • MDS Virtual Congress 2020

    Effects of Rasagiline on Parkinson’s Disease Questionnaire (PDQ-39) Emotional Well-being Domain in Patients with Parkinson’s Disease (PD): A Post-Hoc Analysis of Clinical Trials in Japan

    N. Hattori, A. Takeda, Y. Hanya, T. Kitagawa, M. Arai, Y. Furusawa, H. Mochizuki, M. Nagai, R. Takahashi (Tokyo, Japan)

    Objective: To evaluate the direct and indirect effects of rasagiline on emotional well-being domain of the PDQ-39 in patients with PD by a post-hoc analysis…
  • MDS Virtual Congress 2020

    Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease: ADAPT-PD Trial: A Prospective Single-Blind, Randomized Crossover, Multi-Center Trial of Deep Brain Stimulation Adaptive Algorithms in Subjects with Parkinson’s Disease

    A. Kuhn, L. Tonder, R. Raike, S. Stanslaski, K. Lynch, H. Bronte-Stewart (Berlin, Germany)

    Objective: To demonstrate safety and effectiveness of adaptive deep brain stimulation (aDBS) algorithms in subjects with Parkinson’s disease (PD). Background: DBS is an effective therapy…
  • MDS Virtual Congress 2020

    Serum microRNA expression levels in Turkish patients with Parkinson’s disease

    B. Ozdilek, B. Demircan (Istanbul, Turkey)

    Objective: To determine the serum expression levels of miR-19a, miR-19b, miR-29a, miR-29c, miR-181, miR-195 and miR-221 in Turkish patients with Parkinson's disease (PD) and to…
  • MDS Virtual Congress 2020

    Comparison of gait measures in a clinic and a community setting in people with and without Parkinson’s disease

    V. Shah, J. McNames, M. Mancini, P. Carlson-Kuhta, J. Nutt, M. El Gohary, C. Curtze, F. Horak (Portland, OR, USA)

    Objective: This study aimed to investigate measures that best discriminated gait characteristics of people with Parkinson's disease (PD) from age-matched healthy control subjects (HC) in…
  • MDS Virtual Congress 2020

    On-Demand Treatment Preferences of Patients with Parkinson’s Disease and “OFF” Episodes: Heterogeneity Across Patient Subgroups

    A. Thach, J. Coulter, C. Leach, J. Sutphin, C. Mansfield (Marlborough, MA, USA)

    Objective: To quantify preference heterogeneity for on-demand treatments among patients with Parkinson’s disease (PD) and “OFF” episodes. Background: Patients with PD commonly experience “OFF” episodes.…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley